Itolizumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Itolizumab, covering 2021-01-27 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) [Phase 3]